Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROTECT
NCT07449247Phase 2Not yet recruiting
- Sponsor
- Tianjin Medical University Eye Hospital
- Start
- Mar 2026
- Primary completion
- Jun 2027
- Modality
- Small Molecules, Drug Delivery Systems
01
Overview
A Phase 2 trial of NVK002 in pre-myopia, sponsored by Tianjin Medical University Eye Hospital. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
NVK002
03
Conditions
pre-myopia
Beyond the preview
Go deeper on NCT07449247.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07449247.